Paper42903410PubMed
Targeting lysine acetyltransferase 6A/B in cancer: a conceptual and translational review of epigenetic regulation, immune microenvironment remodeling, and the dual-compartment hypothesis.
Ma C and 4 others. Front Immunol, 2026.
Cite this record
ConductScience Library. Targeting lysine acetyltransferase 6A/B in cancer: a conceptual and translational review of epigenetic regulation, immune microenvironment remodeling, and the dual-compartment hypothesis. Papers, record 42903410. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42903410
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Targeting lysine acetyltransferase 6A/B in cancer: a conceptual and translational review of epigenetic regulation, immune microenvironment remodeling, and the dual-compartment hypothesis.
- Journal
- Front Immunol
- Year
- 2026
- Publication types
- Journal Article, Review, Research Support, Non-U.S. Gov't
- Revised in PubMed
- 2026-10-27
Source PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Tumor Microenvironment | Major topic |
| Epigenesis, Genetic | Major topic |
| Neoplasms | Major topic |
| Histone Acetyltransferases | Major topic |
| Lysine Acetyltransferases | Major topic |
| Humans | |
| Animals | |
| Proteolysis Targeting Chimera | |
| Gene Expression Regulation, Neoplastic | |
| Antineoplastic Agents |
Source PubMed
References117
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 41611522 | Biological Activity and Structural Biology of Current KAT6A Inhibitor Chemotypes. | J Med Chem | 2026 | https://conductscience.org/library/papers/41611522 | PubMed |
| 2 | 30069049 | Inhibitors of histone acetyltransferases KAT6A/B induce senescence and arrest tumour growth. | Nature | 2018 | https://conductscience.org/library/papers/30069049 | PubMed |
| 3 | 28197390 | The immune checkpoint ligand PD-L1 is upregulated in EMT-activated human breast cancer cells by a mechanism involving ZEB-1 and miR-200. | Oncoimmunology | 2017 | https://conductscience.org/library/papers/28197390 | PubMed |
| 4 | 37058271 | SNORD17-mediated KAT6B mRNA 2'-O-methylation regulates vasculogenic mimicry in glioblastoma cells. | Cell Biol Toxicol | 2023 | https://conductscience.org/library/papers/37058271 | PubMed |
| 5 | 40580997 | Phase 1 study of zavondemstat (TACH101), a first-in-class KDM4 inhibitor, in patients with advanced solid tumors. | Oncologist | 2025 | https://conductscience.org/library/papers/40580997 | PubMed |
| 6 | 17320507 | Chromatin modifications and their function. | Cell | 2007 | https://conductscience.org/library/papers/17320507 | PubMed |
| 7 | 35432536 | KAT6B May Be Applied as a Potential Therapeutic Target for Glioma. | J Oncol | 2022 | https://conductscience.org/library/papers/35432536 | PubMed |
| 8 | 41326356 | Immune cells dying from ferroptosis: mechanisms and therapeutic opportunities. | Cell Death Dis | 2025 | https://conductscience.org/library/papers/41326356 | PubMed |
| 9 | 27653692 | Acetylation of the Cd8 Locus by KAT6A Determines Memory T Cell Diversity. | Cell Rep | 2016 | https://conductscience.org/library/papers/27653692 | PubMed |
| 10 | 23063713 | Tandem PHD fingers of MORF/MOZ acetyltransferases display selectivity for acetylated histone H3 and are required for the association with chromatin. | J Mol Biol | 2012 | https://conductscience.org/library/papers/23063713 | PubMed |
| 11 | 29443960 | TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. | Nature | 2018 | https://conductscience.org/library/papers/29443960 | PubMed |
| 12 | 29937226 | LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade. | Cell | 2018 | https://conductscience.org/library/papers/29937226 | PubMed |
| 13 | 38824244 | Inhibition of lysine acetyltransferase KAT6 in ER+HER2- metastatic breast cancer: a phase 1 trial. | Nat Med | 2024 | https://conductscience.org/library/papers/38824244 | PubMed |
| 14 | 37495688 | Rewiring cancer drivers to activate apoptosis. | Nature | 2023 | https://conductscience.org/library/papers/37495688 | PubMed |
| 15 | 38973255 | KAT6A Condensates Impair PARP1 Trapping of PARP Inhibitors in Ovarian Cancer. | Adv Sci (Weinh) | 2024 | https://conductscience.org/library/papers/38973255 | PubMed |
| 16 | 24984779 | Writers and readers of histone acetylation: structure, mechanism, and inhibition. | Cold Spring Harb Perspect Biol | 2014 | https://conductscience.org/library/papers/24984779 | PubMed |
| 17 | 38890285 | The miR-29 family facilitates the activation of NK-cell immune responses by targeting the B7-H3 immune checkpoint in neuroblastoma. | Cell Death Dis | 2024 | https://conductscience.org/library/papers/38890285 | PubMed |
| 18 | 39825161 | The important role of the histone acetyltransferases p300/CBP in cancer and the promising anticancer effects of p300/CBP inhibitors. | Cell Biol Toxicol | 2025 | https://conductscience.org/library/papers/39825161 | PubMed |
| 19 | 41361170 | ERBB2 signaling drives immune cell evasion and resistance against immunotherapy in small cell lung cancer. | Nat Commun | 2025 | https://conductscience.org/library/papers/41361170 | PubMed |
| 20 | 38383216 | Histone lysine acetyltransferase inhibitors: an emerging class of drugs for cancer therapy. | Trends Pharmacol Sci | 2024 | https://conductscience.org/library/papers/38383216 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42903410
GET https://conductscience.org/api/papers/v1/42903410/references?page=2